NCT01698749 Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema Status COMPLETED Phase NA
NCT01661946 Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye Status COMPLETED Phase PHASE3
NCT01640171 Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival Status COMPLETED Phase NA
NCT01635790 Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) Status UNKNOWN Phase PHASE2/PHASE3
NCT01627249 Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT01613716 Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) Status COMPLETED Phase PHASE4
NCT01573572 Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium Status COMPLETED Phase PHASE4
NCT01572350 Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT01571232 Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT01565148 A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Status TERMINATED Phase PHASE2
NCT01552408 Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE) Status COMPLETED Phase PHASE1/PHASE2
NCT01546402 Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema Status COMPLETED Phase PHASE4
NCT01523314 Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema Status UNKNOWN Phase PHASE2/PHASE3
NCT01487044 A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema Status AVAILABLE Phase N/A
NCT01486238 Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study Status COMPLETED Phase PHASE4
NCT01482871 Safety Study of ALG- 1001 to Treat Diabetic Macular Edema Status WITHDRAWN Phase PHASE1/PHASE2
NCT01473251 Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration Status COMPLETED Phase NA
NCT01472510 Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy Status COMPLETED Phase PHASE2